Federal Medicobiological Agency "Konvasel" on elderly in 2022] plans to carry out vaccine test

Federal Medicobiological Agency considers possibility of carrying out tests of a vaccine from Koronavirus "Konvasel" on faces is more senior than 60 years until the end of 2022. "Considering experience of carrying out similar researches, successful results of preclinical and clinical trials, Federal Medicobiological Agency considers possibility of clinical trial of a vaccine "Konvasel" at persons 60 years in 2022" are more senior — the head of Federal Medicobiological Agency Veronika Skvortsova told information agency "ITAR-TASS". "Konvasel" was registered in March. It is developed by the St. Petersburg scientific research institute of vaccines and serums of Federal Medicobiological Agency. Besides it are approved to...